Drugs / Fimaporfin
Fimaporfin
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 14 trials | ||||||
| Phase 1 | NCT02947854 | Sep 2016 → Mar 2018 | — | PCI Biotech AS | Completed | No outcome recorded |
| Phase 1 | NCT01900158 | May 2013 → Feb 2019 | cholangiocarcinoma | PCI Biotech AS | Completed | No outcome recorded |
| Phase 1 | NCT01872923 | Jan → Oct 2012 | skin cancer | PCI Biotech AS | Completed | No outcome recorded |
| Phase 1 | NCT00993512 | Aug 2009 → May 2011 | head and neck neoplasm, skin neoplasm | PCI Biotech AS | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT04099888 | May 2019 → Apr 2022 | cholangiocarcinoma | PCI Biotech AS | Terminated | No outcome recorded |
| Phase 2 | NCT01606566 | Apr 2012 → Aug 2015 | head and neck squamous cell carcinoma | PCI Biotech AS | Terminated | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fimaporfin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02947854 ↗ |
| Known as | Amphinex | “IV administration of Amphinex solution for injection (investigational product) at 0.22 mg/kg dose of fimaporfin” NCT04099888 ↗ |
| Known as | Fimaporfin (Amphinex) | “Fimaporfin (Amphinex)” NCT01900158 ↗ |
| Known as | Fimaporfina | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297882 ↗ |
| Known as | Fimaporfine | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297882 ↗ |
| Known as | TPCS2a | “Fimaporfin (TPCS2a) is a photosensitiser drug being developed by PCI Biotech AS” NCT02947854 ↗1“Amphinex (TPCS2a)” NCT00993512 ↗ |
| Modality | Other / unclassified | “The photosensitizer Amphinex is activated by Laser Light at 652 nm.” NCT01872923 ↗ |
| Route | Intravenous | “Intravenous administration of 0.25 mg/kg Amphinex” NCT01606566 ↗ |